See more : Capital A Berhad (AIABF) Income Statement Analysis – Financial Results
Complete financial analysis of Lysogene S.A. (LYS.PA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Lysogene S.A., a leading company in the Biotechnology industry within the Healthcare sector.
- Benson Hill, Inc. (BHIL-WT) Income Statement Analysis – Financial Results
- Acme Electronics Corporation (8121.TWO) Income Statement Analysis – Financial Results
- Oversea-Chinese Banking Corporation Limited (O39.SI) Income Statement Analysis – Financial Results
- Yangtze Optical Fibre And Cable Joint Stock Limited Company (601869.SS) Income Statement Analysis – Financial Results
- Xinyi Glass Holdings Limited (XYIGF) Income Statement Analysis – Financial Results
Lysogene S.A. (LYS.PA)
About Lysogene S.A.
Lysogene S.A., a biopharmaceutical gene therapy company, focuses on the discovery and development of therapies for children with neurodegenerative lysosomal storage disorders. Its clinical programs include LYS-SAF302, which is in Phase II/III clinical trial for the treatment of mucopolysaccharidosis type IIIA; and LYS-GM101 that is in Phase I/II trial for the treatment of GM1 gangliosidosis. The company has a collaborative research collaboration with the Weizmann Institute of Science for developing a novel AAV gene therapy approach for neuronopathic gaucher disease, parkinson disease, and other diseases. Lysogene S.A. was incorporated in 2009 and is based in Neuilly-sur-Seine, France.
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.73M | 13.37M | 13.37M | 3.59M | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 1.89M | 2.62M | 2.48M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 1.84M | 10.75M | 10.89M | 3.59M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 49.37% | 80.40% | 81.43% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 15.66M | 16.31M | 17.62M | 10.71M | 15.33M | 6.33M | 2.96M | 692.00K |
| General & Administrative | 449.00K | 497.00K | 620.00K | 6.19M | 4.57M | 2.45M | 1.31M | 515.00K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 449.00K | 497.00K | 620.00K | 6.19M | 4.57M | 2.45M | 1.31M | 515.00K |
| Other Expenses | -977.00K | -978.00K | -2.27M | -2.32M | -2.69M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 15.13M | 15.83M | 15.97M | 14.58M | 17.22M | 7.29M | 3.86M | 639.00K |
| Cost & Expenses | 17.02M | 18.45M | 18.46M | 14.58M | 17.22M | 7.29M | 3.86M | 639.00K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 62.00K | 0.00 | 0.00 | 83.00K | 80.00K | 65.00K | 38.00K | 10.00K |
| Depreciation & Amortization | 108.00K | 364.00K | 241.00K | 157.00K | -465.00K | 34.00K | 73.00K | 13.00K |
| EBITDA | -13.18M | -4.71M | -4.84M | -10.80M | -17.68M | -7.39M | -3.64M | -606.00K |
| EBITDA Ratio | -353.34% | -35.25% | -36.21% | -300.78% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -13.29M | -5.08M | -5.08M | -10.96M | -17.22M | -7.29M | -3.86M | -639.00K |
| Operating Income Ratio | -356.23% | -37.98% | -38.01% | -305.15% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -318.00K | -14.00K | 801.00K | 42.00K | -576.00K | -195.00K | 103.00K | 10.00K |
| Income Before Tax | -13.61M | -5.09M | -4.28M | -10.91M | -17.79M | -7.48M | -3.75M | -629.00K |
| Income Before Tax Ratio | -364.75% | -38.08% | -32.02% | -303.98% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 62.00K | 14.00K | -801.00K | 43.00K | 3.00K | -130.00K | 4.00K | 21.00K |
| Net Income | -13.67M | -5.11M | -3.48M | -10.96M | -17.80M | -7.48M | -3.76M | -630.00K |
| Net Income Ratio | -366.42% | -38.19% | -26.03% | -305.18% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.81 | -0.32 | -0.26 | -0.87 | -1.52 | -0.62 | -0.46 | -0.08 |
| EPS Diluted | -0.81 | -0.32 | -0.26 | -0.87 | -1.52 | -0.62 | -0.46 | -0.08 |
| Weighted Avg Shares Out | 16.87M | 15.80M | 13.59M | 12.58M | 11.72M | 12.08M | 8.25M | 8.25M |
| Weighted Avg Shares Out (Dil) | 16.87M | 15.80M | 13.59M | 12.58M | 11.72M | 12.08M | 8.25M | 8.25M |
Source: https://incomestatements.info
Category: Stock Reports